ARS Pharmaceuticals, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 5.51M1.32M0.03M89.15M
Gross Profit 5.51M1.32M0.03M89.15M
Operating items
Research & Development 20.27M18.38M20.27M19.58M
Selling, General & Administrative 4.69M18.46M47.28M71.67M
Other Operating Expenses 0.98M
Operating Expenses 24.96M36.83M67.55M92.23M
Operating Income -19.45M-35.52M-67.52M-3.08M
EBIT -19.45M-35.52M-67.52M-3.08M
Non-operating items
Non Operating Investment Income -0.14M
Other Non Operating Income -0.79M0.97M13.15M11.37M
Non Operating Income -0.79M0.97M13.15M11.37M
Net income details
EBT -19.45M-35.52M-54.37M8.29M
Tax Provisions 0.29M
Profit After Tax -20.24M-34.68M-54.37M8.00M
Income from Continuing Operations -19.45M-35.52M-54.37M8.00M
Consolidated Net Income -19.45M-35.52M-54.37M8.00M
Income towards Parent Company -19.45M-35.52M-54.37M8.00M
Net Income towards Common Stockholders -19.45M-35.52M-54.37M8.00M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 28.52M35.08M36.06M96.00M97.19M
Shares Outstanding (Diluted Average) 28.87M39.96M95.22M102.39M
EBITDA -20.24M-34.27M-54.72M8.17M
Tax Rate 3.48%